Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Avidex licenses diabetes target from King's College London

Oct. 13, 2005

Preclinical data on EP4 receptor agonist ONO-4819

Oct. 13, 2005

Therapeutic agents for osteoporosis reported in recent patent literature

Oct. 11, 2005

Testosterone MDTS improves libido of premenopausal women with low testosterone levels

Oct. 11, 2005

hVps34, a class 3 PI3K, identified as a potential antiobesity target

Oct. 11, 2005

Enzo reports promising preclinical results of potential bone growth compound

Oct. 11, 2005

Promising results reported for LB-03002 in children with GHD

Oct. 10, 2005

Reliant announces U.S. launch of Omacor as diet supplement for very high TG

Oct. 10, 2005

Aastrom Biosciences begins clinical trials with Tissue Repair Cells for limb ischemia

Oct. 10, 2005

Telik to begin clinical studies with oral Telintra

Oct. 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...